P

Psybio Therapeutics Corp
XTSX:PSYB

Watchlist Manager
Psybio Therapeutics Corp
XTSX:PSYB
Watchlist
Price: 0.01 CAD Market Closed
Market Cap: CA$839.3k

Relative Value

PSYB doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of PSYB.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PSYB Relative Value
Base Case
Not Available
P
Worst Case
Base Case
Best Case

Multiples Across Competitors

PSYB Competitors Multiples
Psybio Therapeutics Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Psybio Therapeutics Corp
XTSX:PSYB
809k CAD 0 -0.1 -0.1 -0.1
US
GE Vernova LLC
NYSE:GEV
224.3B USD 0 0 0 0
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR 0 0 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 351.6 4 020.7 3 417.4 3 537.2
NL
Nepi Rockcastle NV
JSE:NRP
107.1B ZAR 6.3 10 15.6 15.7
CH
Galderma Group AG
SIX:GALD
36.5B CHF 0 0 0 0
US
CoreWeave Inc
NASDAQ:CRWV
42.8B USD 0 0 0 0
US
Coupang Inc
F:788
28.6B EUR 1 86.6 22.3 36.8
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
564.8T IDR 47.2 -130.3 2 756.3 2 756.3
ZA
Vukile Property Fund Ltd
JSE:VKE
32B ZAR 6 7.4 18.3 18.3
US
Symbotic Inc
NASDAQ:SYM
32.3B USD 13.4 -2 954.7 -3 946.4 -634.1
P/S Multiple
Revenue Growth P/S to Growth
CA
P
Psybio Therapeutics Corp
XTSX:PSYB
Average P/S: 70.9
Not Available
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
14%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
351.6
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
6.3
-2%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
18%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
1
15%
0.1
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
47.2
N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
6
-24%
N/A
US
Symbotic Inc
NASDAQ:SYM
13.4
25%
0.5
P/E Multiple
Earnings Growth PEG
CA
P
Psybio Therapeutics Corp
XTSX:PSYB
Average P/E: 1 031.2
Negative Multiple: -0.1
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
19%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
10
-5%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
86%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
86.6
114%
0.8
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
Negative Multiple: -130.3 N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
7.4
-5%
N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -2 954.7 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
P
Psybio Therapeutics Corp
XTSX:PSYB
Average EV/EBITDA: 1 246
Negative Multiple: -0.1
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
70%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
3 417.4
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
15.6
9%
1.7
CH
G
Galderma Group AG
SIX:GALD
Not Available
28%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
22.3
56%
0.4
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
2 756.3
N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
18.3
12%
1.5
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -3 946.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
P
Psybio Therapeutics Corp
XTSX:PSYB
Average EV/EBIT: 1 272.8
Negative Multiple: -0.1
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
91%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
3 537.2
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
15.7
8%
2
CH
G
Galderma Group AG
SIX:GALD
Not Available
39%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Coupang Inc
F:788
36.8
74%
0.5
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
2 756.3
N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
18.3
10%
1.8
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -634.1 N/A N/A